Greenwald, Mark K.
Wiest, Katharina L.
Haight, Barbara R.
Laffont, Celine M.
Zhao, Yue
Clinical trials referenced in this document:
Documents that mention this clinical trial
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
https://doi.org/10.1186/s12954-023-00906-7
Article History
Received: 26 April 2023
Accepted: 17 November 2023
First Online: 2 December 2023
Declarations
:
: This study was approved by the Quorum Review Institutional Review Board (IRB# 30013).
: Not applicable.
: CML and YZ are employees of Indivior, Inc. BRH is a former employee of Indivior, Inc. and holds stock. MKG has received compensation for medical education events from Indivior, Inc., unrelated to this manuscript. KLW has received compensation for advisory committee work from Indivior, Inc., unrelated to this manuscript.